W.H.O. New data show that pregnant women has a more severe H1N1 infection compared to others. Evidence from previous pandemics further supports the conclusion that pregnant women are at heightened risk. W.H.O. recommens that all pregnant women start treatment with Tamiflu or Relenza as soon as they develop symptoms.
World The E-CDC list covers countries outside Europe and provide country by country data. Australia report more than 21,000 cases with 63 deaths, China 2090 cases and no deaths, Hong Kong 3904 cases with 3 deaths, japan 2090 cases with no deaths.
U.S.A. The CDC has stopped reporting individual cases the 24 July when 43,771 cases were confirmed. Reports will now focus on hospital admissions and deaths. The 31 July 5,514 people has been admitted to hospital with H1N1 and 353 have died. The latest data clearly show that influenza activity in the U.S. has been declining over the past weeks. More information from the CDC here: H1N1 Flu Situation Update.
Europe 26,513 cases have been reported. The three worst affected countries are the United Kingdom (11,864 cases with 30 deaths), Germany (6,062 cases and no deaths) and Spain (1,538 cases with 7 deaths). including 212 new cases during the past 24 hours and 33 deaths. Most cases have been reported from the United Kingdom, 10,649 with 29 deaths. The list of cases in each country can be found here: E-CDC
United Kingdom the Health protection Agency, HPA, advice special risk groups to contact their doctor rather than use the National Pandemic Influenza Service; these are: people with serious underlying health conditions, pregnant women, children under one or children whose condition suddenly gets worse and those whose condition is still getting worse after 7 days (5 days for a child). Source: HPA
Comment The W.H.O. still recommend no restrictions to international travel.
During the past week pregnant women was added to the list of people with a higher than average risk of a serious attcak of influenza H1N1. Pending a vaccine, pregnant women are advised to start Tamiflu or Relenza as soon as they develop symptoms of influenza, fever, cough and sneezing, musle and joint pains.
Tamiflu or Relenza are not recommended to healthy travellers not belonging to a risk group visiting countries with reported H1N1 influenza. If you belong to a risk group and receive influenza vaccines every winter, or if you are pregnant, you should consider bringing Tamiflu or Relenza with you, if visiting an area with a high number of reported cases.